Home Generics Biosimilars Docs & Positions Facts & Figures Press Room Conferences

Intellectual Property

TopData Exclusivity

Generics & Data Exclusivity

Data exclusivity is not intellectual property protection.
This page from the EGA Web site offers a general explanation of what data exclusivity is, how it works and what the new provisions from the pharma review will mean for generic medicines.
• Up-dated: September 2007

Data Exclusivity and the 2001 Review

An EGA Discussion Paper.
• July 2001

Data Exclusivity: A Major Obstacle to Innovation and Competition in the EU Pharmaceutical Sector

An EGA Position Paper.
• December 2000